• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中脑脊液F2-异前列腺素纵向增加的抑制作用

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

作者信息

Quinn Joseph F, Montine Kathleen S, Moore Milar, Morrow Jason D, Kaye Jeffrey A, Montine Thomas J

机构信息

Department Neurology, Oregon Health and Sciences University, Portland, OR, USA.

出版信息

J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110.

DOI:10.3233/jad-2004-6110
PMID:15004331
Abstract

We report the first longitudinal analysis of cerebrospinal fluid (CSF) F2-isoprostanes (IsoPs), quantitative in vivo biomarkers of lipid peroxidation, in patients with mild Alzheimer's disease (AD). CSF F2-IsoPs (i) were significantly increased in patients followed over one year, (ii) correlated with some clinical indices of dementia following correction for variation in ventricular enlargement, and (iii) were significantly lower in patients who used both alpha-tocopherol and vitamin C.

摘要

我们报告了对轻度阿尔茨海默病(AD)患者脑脊液(CSF)F2-异前列腺素(IsoPs)的首次纵向分析,F2-异前列腺素是脂质过氧化的定量体内生物标志物。脑脊液F2-异前列腺素:(i)在随访一年以上的患者中显著升高;(ii)在校正脑室扩大的变化后,与痴呆的一些临床指标相关;(iii)在同时使用α-生育酚和维生素C的患者中显著降低。

相似文献

1
Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.阿尔茨海默病中脑脊液F2-异前列腺素纵向增加的抑制作用
J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110.
2
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.用于阿尔茨海默病的抗氧化剂:一项采用脑脊液生物标志物检测的随机临床试验
Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.
3
Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease.晚发性阿尔茨海默病早期神经心理症状的脑脊液生物标志物
Int J Neurosci. 2015;125(10):747-54. doi: 10.3109/00207454.2014.971787. Epub 2014 Oct 29.
4
Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers.脑脊液中 F2-异前列腺素含量的增加与衰老和通过生物标志物识别的潜伏性阿尔茨海默病有关。
Neuromolecular Med. 2011 Mar;13(1):37-43. doi: 10.1007/s12017-010-8126-6. Epub 2010 Jul 15.
5
F2-isoprostanes in Alzheimer and other neurodegenerative diseases.阿尔茨海默病及其他神经退行性疾病中的F2-异前列腺素
Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):269-75. doi: 10.1089/ars.2005.7.269.
6
Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease.氧化损伤的定量体内生物标志物及其在阿尔茨海默病诊断和管理中的应用。
J Alzheimers Dis. 2005 Mar;8(4):359-67. doi: 10.3233/jad-2005-8405.
7
Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry.分析 F2-异前列烷和 F4-神经前列腺素在人脑脊液中气相色谱/质谱分析的影响因素。
Biomed Res Int. 2013;2013:810915. doi: 10.1155/2013/810915. Epub 2013 Jul 10.
8
Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners.补充抗氧化剂可预防超级马拉松运动员运动诱导的脂质过氧化,但不能预防炎症。
Free Radic Biol Med. 2004 May 15;36(10):1329-41. doi: 10.1016/j.freeradbiomed.2004.02.069.
9
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.轻度认知障碍患者脑脊液生物标志物的预测及纵向研究
Neurobiol Aging. 2009 May;30(5):682-90. doi: 10.1016/j.neurobiolaging.2007.08.010. Epub 2007 Sep 24.
10
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.非β-淀粉样蛋白/tau 脑脊液标志物可提示阿尔茨海默病的分期和进展。
Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.

引用本文的文献

1
Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease.靶向线粒体钙稳态及信号传导的杂环化合物在阿尔茨海默病和帕金森病中的治疗潜力
Antioxidants (Basel). 2023 Jun 15;12(6):1282. doi: 10.3390/antiox12061282.
2
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease.脑脊液中异前列腺素水平不能反映阿尔茨海默病。
Antioxidants (Basel). 2020 May 10;9(5):407. doi: 10.3390/antiox9050407.
3
Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.
采用 LC-MS 结合均 13C 标记内标分析阿尔茨海默病脑内的类二十烷酸氧化产物。
Free Radic Biol Med. 2018 Apr;118:108-118. doi: 10.1016/j.freeradbiomed.2018.02.019. Epub 2018 Feb 21.
4
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.脑脊液生物标志物在早期阿尔茨海默病诊断中的临床应用价值
Alzheimers Dement. 2015 Jan;11(1):58-69. doi: 10.1016/j.jalz.2014.02.004. Epub 2014 May 3.
5
Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.脂质过氧化引发神经退行性变:阿尔茨海默病大脑的氧化还原蛋白质组学观点。
Free Radic Biol Med. 2013 Sep;62:157-169. doi: 10.1016/j.freeradbiomed.2012.09.027. Epub 2012 Oct 5.
6
Biomarkers for Alzheimer's disease: showing the way or leading us astray?阿尔茨海默病的生物标志物:指明道路还是误导我们?
J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S371-6. doi: 10.3233/JAD-2012-129022.
7
Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.阿尔茨海默病中线粒体和内质网相关的氧化应激:从发病机制到生物标志物
Int J Cell Biol. 2012;2012:735206. doi: 10.1155/2012/735206. Epub 2012 Jun 4.
8
Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.脑脊液和血浆生物标志物在神经退行性疾病和轻度认知障碍诊断中的作用。
Curr Neurol Neurosci Rep. 2011 Oct;11(5):455-63. doi: 10.1007/s11910-011-0212-0.
9
An overview of biomarkers in Alzheimer's disease.阿尔茨海默病生物标志物概述。
Ann Indian Acad Neurol. 2010 Dec;13(Suppl 2):S116-23. doi: 10.4103/0972-2327.74256.
10
Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers.脑脊液中 F2-异前列腺素含量的增加与衰老和通过生物标志物识别的潜伏性阿尔茨海默病有关。
Neuromolecular Med. 2011 Mar;13(1):37-43. doi: 10.1007/s12017-010-8126-6. Epub 2010 Jul 15.